Science
Mechanism of Action
This peptide acts primarily as a skin conditioning agent, signaling the skin to engage its natural repair processes. It also exhibits antioxidant and protective qualities. Certain advanced variants are designed for improved cellular permeability, aiming to modulate the SNARE complex by targeting SNAP-25, thereby reducing acetylcholine release to visually improve the appearance of wrinkles, conceptually mirroring the effects of medical botulinum toxin injections.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Specific optimal pH for stability is not defined. However, related botulinum toxin peptides are often reconstituted in phosphate-buffered saline (PBS), indicating water solubility. For stability, lyophilized forms are typically stored between 2-8°C, while reconstituted solutions are recommended for short-term storage at -70°C.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel has not evaluated this specific peptide for safety. While the full botulinum toxin is FDA-approved for injectables, SR-CLOSTRIDIUM BOTULINUM POLYPEPTIDE-1 does not currently hold FDA topical cosmetic ingredient status. Adverse reactions are infrequent, but a patch test is recommended prior to extensive use. Due to insufficient data on topical use during pregnancy and breastfeeding, professional medical consultation is advised for these populations.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While this peptide demonstrates potential for skin conditioning, antioxidant benefits, and general skin improvement, the ambitious claims regarding its topical botulinum toxin-like wrinkle reduction effects currently lack specific clinical substantiation for topical application and formal safety review by independent bodies, warranting more robust evidence.
Related
Similar Ingredients
Finding similar ingredients…